Rising Prevalence Of Neurological Disorders Fuels Growth In The Neuromodulation Market: Strategic Insights Driving Neuromodulation Market Momentum in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Neuromodulation Market Size By 2025?
In the recent years, the neuromodulation market size has seen robust growth. The market, worth $6.96 billion in 2024, is anticipated to increase to $7.62 billion in 2025 - a compound annual growth rate (CAGR) of 9.5%. Factors such as the escalating prevalence of chronic diseases, increased focus on clinical research and evidence, patient preference for non-invasive treatments, government support and funding, expansion of indications, and strategic collaborations and partnerships have contributed to the growth witnessed in the historic period.

How Big Is the Neuromodulation Market Size Expected to Grow by 2029?
The neuromodulation market is predicted to experience substantial growth in the coming years, expanding to a value of $11.57 billion by 2029 with a compound annual growth rate of 11.0%. This projected growth can be attributed to several factors including the downsizing of devices, a focus on neurological disorders in the elderly, increased use in psychiatry, patient-centric methodology, and greater global healthcare access. Key trends during this projection period encompass the incorporation of artificial intelligence, advancements in technology, non-invasive neuromodulation methods, closed-loop neuromodulation systems, broadening of usage areas, and the advent of wireless and wearable neuromodulation devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

Which Key Market Drivers Powering Neuromodulation Market Expansion and Growth?
The increase in neurological disorders is anticipated to spur the expansion of the neuromodulation market. Neurological disorders, which technically refer to conditions affecting the brain, nerves spread across the human body, and spinal cord, can be treated and controlled through neuromodulation. It shows promise in addressing a variety of neurological diseases and conditions, including Alzheimer's and Parkinson's diseases. For example, the Belgium-based international health organization, European Brain Council, reported in April 2022 that there were over 600 documented neurological diseases and close to 300 psychiatric conditions. Globally, 50 million individuals were affected by Alzheimer's and other types of dementia. Epilepsy, a common condition, impacted 65 million people worldwide. Within Europe, dementia afflicted 10.5 million people, a figure predicted to rise to 18.7 million by 2050. Hence, the neuromodulation market's growth is being propelled by the rising incidence of neurological disorders.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

Which Emerging Trends Are Transforming the Neuromodulation Market in 2025?
Rapid advancements in technology are becoming an increasingly significant trend in the neuromodulation market. Firms that are major players in the field are channeling their efforts towards the invention of new technological solutions in order to consolidate their market position. To illustrate, GrayMatters Health, a digital self-neuromodulation therapies firm from Israel, introduced a novel FDA-approved self-neuromodulation therapy in January 2024, known as Prism. This therapy uses an EEG cap along with software to help patients handle their emotional reactions through neurofeedback. The therapy's goal is to combine with regular psychotherapy and pharmacotherapy, equipping patients with strategies to actively deal with their symptoms. Moreover, in December 2022, Abbott Laboratories, a US-based company specializing in healthcare and medical devices, unveiled the Eterna spinal cord stimulation (SCS) system, a compact implantable, rechargeable spinal cord stimulator. Eterna SCS incorporates the unique low-dose BurstDR stimulation patented by Abbott. This is the only SCS waveform innovation with the highest level of clinical validation (1A evidence), and is proven to alleviate pain by an additional 23% compared to standard waveform technology methods.

What Are the Emerging Segments in the Neuromodulation Market?
The neuromodulation market covered in this report is segmented -

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)
2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial
3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications
4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:
1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems
2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

Who Are the Global Leaders in the Neuromodulation Market?
Major companies operating in the neuromodulation market include Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd, Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

Which are the Top Profitable Regional Markets for the Neuromodulation Industry?
North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10142

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.